´ëÇѳúÁ¹ÁßÇÐȸ (¿Â¶óÀÎ) 12/5(Åä) APSC(Asia Pacific Stroke Conference) 2020 : 2020-12-05±³À°ÀÏÀÚ : 2020-12-05
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 12/5(Åä) APSC(Asia Pacific Stroke Conference) 2020 ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-2277-1919
À̸ÞÀÏ :
stroke@stroke.or.kr ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í 1.»çÀüµî·ÏA)ȸ¿ø(Àü¹®ÀÇÁ¤È¸¿ø 5¸¸¿ø/Àü°øÀÇÁØȸ¿ø, ÀϹÝȸ¿ø 3¸¸¿ø)B)ºñȸ¿ø(Àü¹®ÀÇ 7¸¸¿ø/Àü°øÀÇ,°£È£»ç,¿¬±¸¿ø,±â»ç 5¸¸¿ø)2.ÇöÀåµî·ÏA)ȸ¿ø(Àü¹®ÀÇÁ¤È¸¿ø 7¸¸¿ø/Àü°øÀÇÁØȸ¿ø,ÀϹÝȸ¿ø 5¸¸¿ø)B)ºñȸ¿ø(Àü¹®ÀÇ 10¸¸¿ø/Àü°øÀÇ,°£È£»ç,¿¬±¸¿ø,±â»ç 7¸¸¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 10:00~10:10 APSO Perspectives Kay-Sin Tan(University of Malaya Malaysia)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 10:10~10:20 KSS Perspectives Joung-Ho Rha(Korean Stroke Society)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 10:20~10:30 WSO Perspectives Marc Fisher(Harvard Medical School USA)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 10:30~10:55 Advances in Precision Medicine in the Field of Cerebrovascular Disease Jonathan Rosand(Massachusetts General Hospital USA)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 10:55~11:20 Histological Composition of Thrombus for Stroke Mechanism Ji Hoe Heo(Severance Hospital Korea)
Åä·Ð 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 11:20~11:30 Q&A ()
ÈÞ½Ä 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 11:30~11:50 Break ()
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 11:50~12:15 Late Time Window Strategy Joung-Ho Rha(Inha University Hospital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 12:15~12:40 New Decision Making Platform for Acute Endovascular Therapy David S. Liebeskind(UCLA School of Medicine USA)
Åä·Ð 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 12:40~12:50 Q&A ()
ÈÞ½Ä 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 12:50~13:10 Break ()
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 13:10~13:30 The Benefit of Ezetimibe/Atorvastatin FDCs for Ischemic Stroke Patients with Hypercholesterolemia Kwang Yeol Park(Chung-Ang University Hospital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 13:30~13:50 Recent Hypertension Guidelines Update & Unchanged Value of Cozaar Over 20 Years Mi Sun Oh(Hallym University Sacred Heart Hospital Korea)
Åä·Ð 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 13:50~14:00 Q&A ()
ÈÞ½Ä 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 14:00~14:20 Break ()
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 14:20~14:45 Recent Public Impact of Stroke in Asia Pacific Region N. V. Ramani(Raffles Neuroscience Centre Singapore)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 14:45~15:10 How Does Asian Stroke Differ Western Stroke? Jong S. Kim(Asan Medical Center Korea)
Åä·Ð 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 15:10~15:20 Q&A ()
ÈÞ½Ä 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 15:20~15:40 Break ()
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 15:40~15:50 Etiological Stroke Subtypes and Functional Outcomes in Chronic Kidney Disease: Japan Stroke Data Bank Kaori Miwa(National Cerebral and Cardiovascular Center Osaka (NCVC))
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 15:50~16:00 Evaluation of Original and Modified ICH Score for Predicting 30-day Mortality and Good Outcome for Non-Traumatic Intracerebral Hemorrhage Andreas Soejitno(Udayana University Bali Indonesia)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 16:00~16:10 Stroke Epidemiology in Bangladesh Muzharul Mannan(Banagabandhu Sheikh Mujib Medical University Bangladesh)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 16:10~16:30 Blood Pressure Management after Endovascular Thrombectomy Andrew Lee(Flinders University Australia)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 16:30~16:50 Blood Pressure Target for Stroke Survivors Sun U. Kwon(Asan Medical Center Korea)
Åä·Ð 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 16:50~17:10 Panel Discussion Johnny Lokin(Philippines) Yang-Ha Hwang (Korea)(University of Santo Tomas Philippines / Kyungpook National University Hospital Kore)
ÈÞ½Ä 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 17:10~17:30 Break ()
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 17:30~17:40 The Association between Glucose Control and Composite Vascular Events according to The Subtypes of Ischemic Stroke Jun Young Chang(Asan Medical Center Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 17:40~17:50 Vertebral and Amygdala Glucose Uptake among Cerebral Infarction Patients and Its Impact on Stroke Recurrence Jeong-min Kim(Seoul National University Hospital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 17:50~18:00 The Effects of Triglyceride-Glucose (TyG) Index on Leptomeningeal Collateral Status and Outcome of Reperfusion Therapy in Patients with Acute Ischemic Stroke Minwoo Lee(Hallym University Sacred Heart Hospital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 18:00~18:20 DM and Stroke in Asian Pacific Regions Jeyaraj Pandian(Christian Medical College India)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 18:20~18:40 What is Optimal Therapeutic Glucose Control Strategy for Stroke? Yerim Kim(Kangdong Sacred Heart Hostpital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 18:40~19:00 What is Optimal Therapeutic Glucose Control Strategy for Stroke? Yohanna Kusuma (Indonesia) Bum Joon Kim (Korea)(National Brain Centre Indonesia / Asan Medical Center Korea)
ÈÞ½Ä 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 19:00~19:20 Break ()
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 19:20~19:30 Association of ELOVL6 Gene with Large Artery Atherosclerosis Stroke Risk through Nod-like Receptor Protein Inflammasome Pathway Hua Liu(Sichuan University China)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 19:30~19:40 Predicting Significant Neurological Progression in Vertebrobasilar Artery Occlusion Seungyon Koh(Hanyang University Guri Hospital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 19:40~19:50 Atherosclerotic Burden and Vascular Risk in Stroke Patients with Atrial Fibrillation Jong-ho Park(Hanyang University Myongji Hospital Korea)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 19:50~20:10 What is an Optimal Target of LDL Cholesterol for Stroke Survivors? Pierre Amarenco(Paris University France)
±³À°½Ã°£ 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 20:00~20:20 Nonstatin Therapy for Stroke Prevention Woo-Keun Seo(Samsung Medical Center Korea)
Åä·Ð 12¿ù 05ÀÏ ¿Â¶óÀÎ(Room A) 20:20~20:40 Panel Discussion Shinichiro Uchiyama (Japan) Mi Sun Oh (Korea)(International University of Health and Welfare Japan / Hallym University Sacred Heart Hospital Korea)